Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
HeadsUp Presents: The presentation will focus on antipsychotic mechanisms with emphasis on efficacy and some consideration on side effects. We will talk about the state of present utilization of clozapine for treatment resistant schizophrenia with a focus on initiation and maintenance treatment as well as the relative advantages of long acting injectables to promote clinical improvement and adherence to care.
Objectives:
Based on clinical cases, identify suitable medication choices.
Promote understanding of effectiveness of clozapine and potential augmentation treatment.
Understand the setting where long acting injectables can be useful and how to negotiate use with clients and caregivers.
Catherine (Cat) Conroy, M.Ed, Manager of HeadsUp
Neurodevelopment and Psychosis Section, Department of Psychiatry
Perelman School of Medicine, University of Pennsylvania
10th floor, Gates Pavilion, HUP
3400 Spruce Street, Rm. 10054, Philadelphia, PA 19104
headsuppaorg@gmail.com
We are available during standard business hours (Monday-Friday, 9am-5pm) to answer any questions you may have about our organization or to direct you to programs in Pennsylvania that can offer clinical help.
